Mizuho's Jared Holz on drug price negotiations: More difficult for industry to get better medicines

Jared Holz, Mizuho Securities healthcare sector specialist, joins 'Squawk Box' to discuss the latest on drug price negotiations, as the Biden administration is set to announce the first 10 prescription drugs targeted for Medicare price negotiations this morning, the impact on pharmaceutical companies, and more.